video Finance Videos
Pfizer's patent pain over Viagra
Friday, June 28, 2013 - 02:19
June 28 - Goodbye Viagra, hello competition! Angeline Ong takes a look at Pfizer's fortunes as Viagra's UK patent expires.
▲ Hide Transcript
▶ View Transcript
EDITORS PLEASE NOTE: RESENDING VIDEO WITH MISSING GRAPHIC Michael Douglas, Kim Catrall, Bob Dole and Pele. What links these four people together? Viagra! Whether they've used it or promoted it.. This little blue pill has invigorated their lives along with millions of couples. Now, Viagra may be about to become much cheaper - it loses patent protection in the UK in June, meaning rival manufacturers can get in on the action. (SOUNDBITE) (English) PAUL FLEMING, TECHNICAL DIRECTOR OF THE BRITISH GENERIC MANUFACTURERS ASSOCIATION, SAYING: 'Certainly we're aware that there's alot of companies with regulatory approval already in place… and there's about 20 of those and from that at least a dozen or so will actually launch a product later this month. So we do expect the price decline to be very rapid and very steep. So in fact we'd expect the price to go down by 90% very quickly.' That would slash the price of a pill from around 10-pounds down to as little as 1-quid - the price of a pack of gum. This would torpedo the online Viagra black market. And lead to big savings for the UK's national health service, which spent around 40-million-pounds on the drug last year. So, how much is this gonna hurt the maker of Viagra? Put it this way, Pfizer got slammed after its 10-billion-dollar-a-year cholesterol fighting drug - Lipitor - lost its patent protection in the fall of 2011. Global sales plunged 71% in Q-4 2012 to 584-million. Viagra alone brought in almost 2 billion in sales in 2010 worldwide. Pfizer is HITTING back. It's launching its own cut price version of the drug - called Sildenafil Pfizer - to hang on to market share. But this may not be enough to stay on top of its game. (SOUNDBITE) (English) - PAUL FLEMING, TECHNICAL DIRECTOR OF THE BRITISH GENERIC MANUFACTURERS ASSOCIATION, SAYING: 'The great majority of prescriptions are already written with the generic name, so they're not written with the name Viagra, and because of that, once the patent expires, the great majority of patients will immediately be switched to one of these many generic formulations that will be available so Pfizer will be competing amongst that field of double digit competitors' The fight for domination will be fierce given the use of Viagra is rising in the UK and around the world. The question is - does Pfizer have 'staying power,' as one of the world's most potent brands all but disappears.
Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code
Pfizer's patent pain over Viagra
Friday, June 28, 2013 - 02:19
Top News »
2:18pm EST - (1:55)
1:41pm EST - (1:01)
8:38am EST - (1:23)
8:00am EST - (2:19)
12:38am EST - (1:29)
Tue, Feb 19, 2019 - (0:46)
Tue, Feb 19, 2019 - (1:00)
Tue, Feb 19, 2019 - (1:28)
Tue, Feb 19, 2019 - (0:55)
Tue, Feb 19, 2019 - (2:13)
Tue, Feb 19, 2019 - (1:29)
Tue, Feb 19, 2019 - (0:21)
Migrant Crisis »
Thu, Nov 15, 2018 - (2:23)
Thu, Nov 15, 2018 - (1:26)
Fri, Mar 16, 2018 - (0:50)
Fri, Dec 22, 2017 - (1:52)
Fri, Dec 22, 2017 - (1:07)
Fri, Dec 22, 2017 - (1:37)
Editors' Picks »
8:37am EST - (1:34)
2:28am EST - (1:13)
Tue, Feb 19, 2019 - (1:31)
Mon, Feb 18, 2019 - (1:52)
Fri, Feb 15, 2019 - (1:55)
Thu, Feb 14, 2019 - (2:50)
Thu, Feb 14, 2019 - (2:00)
Thu, Feb 14, 2019 - (1:24)
Thu, Feb 14, 2019 - (1:58)
Thu, Feb 14, 2019 - (1:15)
Politics »
8:38am EST - (1:23)
Tue, Feb 19, 2019 - (1:49)
Tue, Feb 19, 2019 - (1:00)
Tue, Feb 19, 2019 - (0:55)
Tue, Feb 19, 2019 - (2:13)
Tue, Feb 19, 2019 - (1:29)
Tue, Feb 19, 2019 - (0:21)
Mon, Feb 18, 2019 - (1:50)
Mon, Feb 18, 2019 - (2:15)
Mon, Feb 18, 2019 - (1:19)
Mon, Feb 18, 2019 - (1:28)
Mon, Feb 18, 2019 - (0:21)
Innovations »
11:32am EST - (1:13)
10:58am EST - (2:06)
6:29am EST - (1:42)
Tue, Feb 19, 2019 - (1:53)
Mon, Feb 18, 2019 - (1:34)
Fri, Feb 15, 2019 - (1:20)
Fri, Feb 15, 2019 - (1:13)
Thu, Feb 14, 2019 - (1:23)
Thu, Feb 14, 2019 - (1:21)
Thu, Feb 14, 2019 - (1:57)
Entertainment »
2:10pm EST - (1:07)
7:16am EST - (1:09)
1:17am EST - (1:08)
Tue, Feb 19, 2019 - (1:45)
Tue, Feb 19, 2019 - (2:19)
Mon, Feb 18, 2019 - (2:21)
Mon, Feb 18, 2019 - (2:19)
Mon, Feb 18, 2019 - (1:50)
Sun, Feb 17, 2019 - (1:49)
Sun, Feb 17, 2019 - (2:23)
Sun, Feb 17, 2019 - (2:08)
Sun, Feb 17, 2019 - (2:09)
Rough Cuts »
2:18pm EST - (1:55)
6:29am EST - (0:54)
Tue, Feb 19, 2019 - (1:00)
Tue, Feb 19, 2019 - (0:55)
Tue, Feb 19, 2019 - (1:00)
Tue, Feb 19, 2019 - (2:13)
Tue, Feb 19, 2019 - (0:21)
Tue, Feb 19, 2019 - (0:46)
Mon, Feb 18, 2019 - (2:21)
Mon, Feb 18, 2019 - (1:50)
Mon, Feb 18, 2019 - (1:28)
Mon, Feb 18, 2019 - (0:21)
Moving Pictures »
Fri, Feb 01, 2019 - (2:27)
Wed, Jan 02, 2019 - (2:29)
Mon, Dec 17, 2018 - (2:17)
Fri, Nov 30, 2018 - (2:45)
Thu, Nov 22, 2018 - (2:41)
Mon, Oct 01, 2018 - (2:30)
Fri, Aug 31, 2018 - (2:23)
Tue, Jul 31, 2018 - (1:44)
Fri, Jun 29, 2018 - (2:05)
Fri, Jun 01, 2018 - (2:38)
Reuters Investigates »
Wed, Oct 11, 2017 - (10:18)
Wed, Aug 23, 2017 - (6:44)
Thu, Mar 16, 2017 - (2:26)
Tue, Nov 01, 2016 - (2:15)
Thu, Sep 29, 2016 - (2:19)
Fri, Aug 05, 2016 - (2:04)
Mon, Mar 28, 2016 - (3:02)
Thu, Mar 10, 2016 - (2:34)
Mon, Dec 07, 2015 - (2:58)
Mon, Dec 07, 2015 - (2:20)
Mon, Dec 07, 2015 - (0:35)
Mon, Dec 07, 2015 - (3:53)
Dateline Asia »
Mon, Feb 18, 2019 - (1:05)